Duchenne muscular dystrophy (DMD) is a neuromuscular disease caused by mutations in the dystrophin gene. The subcellular mechanisms of DMD remain poorly understood and there is currently no curative treatment available. Using a Caenorhabditis elegans model for DMD as a pharmacologic and genetic tool, we found that cyclosporine A (CsA) reduces muscle degeneration at low dose and acts, at least in part, through a mitochondrial cyclophilin D, CYN-1. We thus hypothesized that CsA acts on mitochondrial permeability modulation through cyclophilin D inhibition. Mitochondrial patterns and dynamics were analyzed, which revealed dramatic mitochondrial fragmentation not only in dystrophic nematodes, but also in a zebrafish model for DMD. This abnormal mitochondrial fragmentation occurs before any obvious sign of degeneration can be detected. Moreover, we demonstrate that blocking/delaying mitochondrial fragmentation by knocking down the fission-promoting gene drp-1 reduces muscle degeneration and improves locomotion abilities of dystrophic nematodes. Further experiments revealed that cytochrome c is involved in muscle degeneration in C. elegans and seems to act, at least in part, through an interaction with the inositol trisphosphate receptor calcium channel, ITR-1. Altogether, our findings reveal that mitochondria play a key role in the early process of muscle degeneration and may be a target of choice for the design of novel therapeutics for DMD. In addition, our results provide the first indication in the nematode that (i) mitochondrial permeability transition can occur and (ii) cytochrome c can act in cell death.
INTRODUCTION
Duchenne muscular dystrophy (DMD, OMIM 310200) is the most prevalent X-linked recessive neuromuscular disorder, affecting striated and cardiac muscles with an incidence of 1 out of 3000 male births. It is caused by mutations in the dystrophin gene (1) . Dystrophin is a large cytoskeletal protein that links the cytoskeleton to the extracellular matrix (2) .
Current treatments for DMD consist of long-term medication with the steroid prednisone, physiotherapy and specific bracing, but these interventions only slightly prolong ambulation in patients (3) . Moreover, since severe side effects often accompany prednisone treatment, it is debatable whether its benefits outweigh its adverse effects. Therefore, the search for efficient palliative treatments is of great value. In addition, identifying the mechanism of action of beneficial drugs may help to understand better the physiopathology of this genetic disease.
The nematode Caenorhabditis elegans exhibits 95 striated body-wall muscle cells that are distributed in four longitudinal bands, named quadrants (Supplementary Material, Fig. S1 ). These muscle cells do not fuse, are not able to regenerate and, to our knowledge, do not undergo inflammatory processes after damage. We previously developed a C. elegans model for * To whom correspondence should be addressed. Tel: +61 291144208, Fax: +61 293510599; Email: jean.giacomotto@sydney.edu.au, giacomottojean@ gmail.com (J.G.); Tel: +33 472432951; Fax: +33 472432951; Email: kathrin.gieseler@univ-lyon1.fr (K.G.) DMD (4) . In this model, a mutation in the dystrophin gene, dys-1, is coupled with a hypomorphic mutation in the C. elegans MyoD gene, hlh-1 (Supplementary Material, Table S1 ). Single dys-1(cx18) mutants present only weak muscle degeneration. In adult worms, up to two muscle cells are occasionally absent. However, combined with the hypomorphic hlh-1(cc561) allele, the dys-1(cx18) allele leads to progressive paralysis due to extensive muscle degeneration, which is time-and activitydependent (Supplementary Material, Video S1) (4) . The degenerative phenotype is generally observed after actin filament staining with phallodin -rhodamine and can be quantified by scoring muscle cells with disrupted or absent actin filaments (Supplementary Material, Fig. S1 ). The use of this nematode model as a tool for chemical screens provides an alternative to traditional screening systems and fills the gap in seeking drugs against DMD (5, 6) . Indeed, this approach led to the identification of drugs that have been further validated in the mdx mouse model for DMD (7, 8) .
In mammals, the subcellular mechanisms that lead to muscle degeneration are poorly understood. It is, however, commonly accepted that loss of dystrophin function induces intracellular Ca 2+ overload. In C. elegans, Ca 2+ transients have also been found to play a critical role in the degenerative process. Reducing the activity of the L-type voltage-gated EGL-19 or the Ryanodine Receptor UNC-68 calcium channels in the nematode DMD model diminishes muscle degeneration (9, 10) .
Mitochondria are dynamic organelles whose morphology and function are controlled by a balance between fission and fusion events (11) . Under normal physiologic conditions, fusion predominates and the mitochondrial network presents mostly tubular morphology (12) . However, under particular conditions such as high intracellular Ca 2+ concentration, oxidative stress, aging or activation of apoptotic and necrotic signals, the dynamic balance is shifted to fission, leading to mitochondrial network fragmentation (13) . In such conditions, mitochondrial permeability transition (mPT) of mitochondrial membranes and the opening of large pores called mitochondrial permeability transition pores (mPTP) can occur and cause the cytosolic release of apoptotic factors (14) . One of the released factors is cytochrome c, which is known in mammals to trigger apoptosis through its interaction with APAF-1 (15) . When mPT is not reversed in a timely manner, cytosolic accumulation of these factors can lead to cell death. Several studies have shown that a mitochondrial matrix prolyl cis -trans isomerase, cyclophilin D, controls Ca 2+ and reactive oxygen species-dependent mPT (16) . Targeting cyclophilin D with chemicals, such as the specific cyclophilin inhibitor Debio025, can reduce apoptotic signals release and cell death (17) .
Cyclosporine A (CsA) is well known as an immunosuppressive drug, which is generally used after organ transplantation to prevent rejection. This compound has the ability to bind cytosolic cyclophilin A to form a complex that inhibits calcineurin, thus leading to lower T cell activity and immune response (18) . CsA was suspected to be beneficial for DMD patients, as they present chronic muscle inflammation potentially due to calcium-dependent activation of calcineurin (19) . In addition, CsA also exerts a calcineurin-independent effect on mPTP opening through cyclophilin D inhibition (20) .
Using the C. elegans DMD model as a chemical screening tool, we found that CsA reduces dystrophin-dependent muscle degeneration at low dose but loses its positive effect at high dose. Our data further indicate that its beneficial effect involves a C. elegans mitochondrial cyclophilin D homolog, CYN-1, suggesting an implication of mPT in muscle degeneration in C. elegans. This finding also provides the first indication that mPT can occur in C. elegans (reviewed in 21). Furthermore, we show that mitochondrial dynamics is dramatically affected at the early stages of muscle degeneration not only in dystrophic nematodes but also in a zebrafish model for DMD. Moreover, we demonstrate that knockdown of the fission-promoting gene drp-1 reduces both mitochondrial fragmentation and muscle degeneration in dystrophic nematodes. This observation suggests (i) that mitochondrial fragmentation observed in dystrophic muscles is due to increased mitochondrial fission, and (ii) that mitochondrial fission plays a key role in the early process of muscle degeneration. We further demonstrate a role for cytochrome c and the inositol trisphosphate receptor (IP3R) calcium channel, ITR-1, in both mitochondrial fission and muscle degeneration. Thus, our study also unveils for the first time, to our knowledge, that in C. elegans cytochrome c is involved in muscle cell death by acting, at least partially, through an interaction with IP3R/ITR-1.
RESULTS

CsA reduces muscle degeneration in dystrophin-deficient nematodes
Using the C. elegans dys-1; hlh-1 model for DMD to search for potential bioactive drugs against muscle degeneration, we found that worms grown on agar medium supplemented with 100 nM CsA moved better than control animals treated with the solvent DMSO. Examination of body-wall muscle cells after phalloidin -rhodamine staining revealed a reduction of muscle degeneration by .50% ( Fig. 1A and 2D ; Supplementary Material, Fig. S1 ). Dose-response experiments showed an optimal effect of CsA against muscle degeneration at concentrations between 10 and 100 nM (Fig. 1A) . This beneficial effect gradually decreased with lower doses, and was no longer significant at 0.1 nM and below. The beneficial effect of CsA on muscle degeneration of dys-1; hlh-1 double mutants was lost at high dose. Above 10 mM, CsA exhibited no significant effects on muscle degeneration (Fig. 1A) . At 100 mM, it induced moderate growth retardation, and at a concentration of ≥500 mM it induced lethality (Fig. 1A) .
Muscle degeneration in the worm model for DMD is caused by the synergistic effect of the dys-1 and hlh-1 mutations, as the mild hlh-1(cc561) mutation serves as an amplifier of the dys-1(cx18) phenotype. To confirm a specific effect on the dys-1-dependent phenotype, CsA was also tested at a concentration of 100 nM on dys-1 single mutants and we found that it led to a significant decrease of muscle degeneration compared with control worms (Supplementary Material, Fig. S2A ).
Muscle degeneration in the nematode is both activity-and time-dependent. Consequently, chemicals that have a sedative effect or that slow down development can reduce muscle degeneration. To exclude the possibility that CsA acted through these indirect effects, we analyzed its impact on mobility and growth rate. At a concentration of 100 nM in the medium, CsA had no significant impact on the growth rate of dys-1; hlh-1 double Fig. S2B ). In addition, a concentration of 100 nM of CsA had no effect on the locomotion of dys-1 single mutants or wild-type worms but significantly improved the mobility of dys-1; hlh-1 double mutants (Supplementary Material, Fig. S2C ). These results demonstrated that the beneficial effect of CsA on muscle degeneration in the dys-1; hlh-1 double mutants was due to an improvement of muscle functions rather than to a sedative effect or reduced growth rate.
Genetic inhibition of the mitochondrial cyclophilin D ortholog, CYN-1, mimics CsA treatment
In mammals, CsA has both an anti-inflammatory effect via calcineurin inhibition and an inhibitory effect on mPTP opening through cyclophilin D. As inflammatory responses are unlikely to contribute to muscle injuries in C. elegans, we tested whether the genetic inhibition of cyclophilin D could reduce muscle degeneration in C. elegans. Blast experiments using murine cyclophilin protein sequences (NP_032933. Fig. S3 ). Moreover, the Mitoprot software revealed the presence of a 21-amino-acid mitochondrial targeting sequence required for mitochondrial translocation, and predicted a probability of mitochondrial export of .90% (22) (Fig. 1C) . CYN-1 seems to be the sole mitochondrial cyclophilin in C. elegans as the Mitoprot score for the 15 other cyclophilin orthologs ranged from 0 to maximal 20% (Fig. 1C) . Finally, as observed with CsA treatment, the RNAi-mediated knockdown of cyn-1 did not modify the growth rate of dys-1; hlh-1 double mutants, dys-1 single mutants or wild-type worms (Supplementary Material, Fig. S2B ). cyn-1 RNAi further had no effect on the locomotion of dys-1 single mutants or wild-type worms, whereas the mobility of dys-1; hlh-1 double mutants was significantly improved (Supplementary Material, Fig. S2C ).
CsA acts through CYN-1 inhibition to reduce muscle degeneration
To determine whether the beneficial effects of CsA and cyn-1 RNAi could be mediated through common mechanisms, muscle degeneration was quantified in dys-1; hlh-1 double mutants treated with different doses of CsA and subjected or not to cyn-1 RNAi (Fig. 1D and 2D ). Worms subjected to (E) Dose-response curve of CsA on muscle degeneration in the dys-1(cx18); hlh-1(cc561) mutant animals subjected to cah-4 RNAi (red curve) or control RNAi (empty L4440 plasmid, blue curve). Animals were grown for 8 days at 158C. Means of 20 nematodes + standard error of the mean. Different from control at * P , 0.05, * * P , 0.01, * * * P , 0.001. †Lethal; GR, growth retardation. (Fig. 1D ). Toxic doses leading to growth retardation (100 mM) and lethality (500 mM) were not modified by cyn-1 RNAi treatment, suggesting that the observed toxicity was not related to CYN-1 inhibition. In contrast, RNAi constructs targeting cyn-2 to -16 failed to modify the CsA dose -response curve on muscle degeneration (data not shown). In order to verify the specificity of cyn-1 RNAi on the effect of CsA, we performed the same dose -response experiments by knocking down the cah-4 gene (cah-4, carbonic anhydrase 4). cah-4 encodes one of the six putative carbonic anhydrases of the worm, and has previously been found to reduce muscle degeneration in C. elegans when knocked down by RNAi (8) . The RNAi-mediated knockdown of cah-4 failed to modify the profile of the CsA dose -response curve (Fig. 1E) . Altogether, these results indicate that CsA and cyn-1 knockdown act through common mechanisms to reduce muscle degeneration. The close homology of the C. elegans CYN-1 protein with mouse cyclophilin D along with its putative mitochondrial localization and its effect on the dose -response curve of CsA suggests that mPT occurs in C. elegans, and that the genetic or pharmacologic inhibition of CYN-1 protects from muscle degeneration by blocking or delaying mPTP opening.
Dystrophin-deficient nematodes present abnormal mitochondrial network morphology
Considering that mPT may be involved in the process of muscle degeneration, mitochondrial morphology and dynamics were analyzed. For this purpose, we took advantage of the ccIs4251 transgene, which drives the expression of the green fluorescent protein (GFP) in body-wall muscle cells where GFP localizes to nuclei and mitochondria (23) . This transgene was genetically introduced into dystrophin-deficient dys-1(cx18) and dys-1(cx18); hlh-1(cc561) as well as into hlh-1(cc561) mutants (Supplementary Material, Video S1, Table S1 ). The morphology of the mitochondrial network reflected by the GFP signal observed by confocal microscopy unveiled dramatic mitochondrial fragmentation in all analyzed strains compared with control worms (PD4251 strain) ( Fig. 2A-C ; Supplementary Material, Fig. S4 ). Eight-day-old adult control worms presented 81 + 2.4% of muscle cells with tubular mitochondria. In hlh-1 or dys-1 single mutants, this proportion was reduced to 66 + 3.5 and 56 + 4.4%, respectively, whereas dys-1(cx18); hlh-1(cc561) double mutants exhibited only 32 + 2.9% of cells with tubular-shaped mitochondria (Fig. 2B) . Interestingly, dys-1; hlh-1 double mutants presented 16 + 2.1% of degenerating muscles cells, and dys-1 and hlh-1 single mutants 2 + 0.7 and 2 + 0.8%, respectively. Thus, it appears that the severity of the changes in mitochondrial network morphology was correlated with the muscle degeneration phenotype. Importantly, mitochondrial network modifications precede sarcomeric defects as observed by disrupted actin filaments stained with phalloidinrhodamine (Supplementary Material, Fig. S5 ). Altogether, our data suggest that morphologic defects of mitochondria may be an early process in dystrophin-dependent muscle degeneration.
Mitochondrial fragmentation further increased with age, regardless of the considered strains (Fig. 2C ). This pattern is in accordance with previous studies, which link mitochondrial fragmentation to the aging process of muscle cells (24) . However, fragmentation progression of the mitochondrial network in muscles of dys-1; hlh-1 double mutants is dramatically increased over time, as after 9 days of culture at 158C only 13 + 2.9% of muscle cells still presented tubular mitochondria compared with 74 + 5.5% in the PD4251 control strain (Fig. 2C ).
Reducing mitochondrial fission reduces muscle degeneration
Mitochondrial phenotypes observed in the dys-1; hlh-1 double mutant suggest that mitochondrial defects are involved in the muscle degenerative process. RNAi-mediated knockdown of the fission-promoting dynamin-related drp-1 gene was carried out to establish whether the loss of the tubular mitochondrial shape detected in muscle cells of dystrophic worms was due to increased mitochondrial fission. Knockdown of drp-1 by RNAi in dys-1; hlh-1 double mutants reduced muscle degeneration by almost 40% compared with control worms (Fig. 2D) . Growth rate remained unchanged in wild-type control worms as well as in dys-1(cx18) single and dys-1; hlh-1 double mutants (Supplementary Material, Fig. S2B ). Locomotion was not modified in dys-1 single mutants or wild-type worms, whereas drp-1 knockdown significantly improved locomotion abilities of dys-1; hlh-1 double mutants (Supplementary Material, Fig. S2C ). Moreover, LS761 dys-1(cx18) ccIs4251; hlh-1(cc561) mutants subjected to drp-1 RNAi presented fewer muscle cells with fragmented mitochondria compared with control worms (Fig. 3 ). These data confirm that mitochondrial fission is likely to contribute to muscle degeneration in dystrophic nematodes and that reducing fission delays muscle degeneration progression.
Mitochondrial network abnormality is also an early event of muscle degeneration in a zebrafish DMD model Mitochondria pattern and distribution were analyzed in a zebrafish DMD model, named dmd pc2 (25) . Homozygous dmd pc2+/+ embryos and larvae present many hallmarks of human DMD patients, including muscle degeneration, fibrosis and inflammatory response. The first obvious sign of muscle degeneration in dmd pc2+/+ embryos is the detachment of some muscle fibers from their myotendinous junction starting at 3 days postfertilization (d.p.f.). To visualize the mitochondrial network and dynamics in muscle fibers of homozygous dmd pc2+/+ animals, a plasmid that drives the expression of mitochondriatargeted GFP in striated muscle was injected into one-cell-stage embryos obtained from heterozygous dmd pc2+/2 incrosses. Similar to dystrophic C. elegans muscles, myofibers of dystrophin-deficient dmd pc2+/+ zebrafish embryos and larvae exhibited fragmented mitochondria ( Fig. 4 ; Supplementary Material, Fig. S6 and S7). All dystrophic muscle fibers that have detached from the myotendinous junction, and appeared retracted, presented a mitochondrial network with a pronounced fragmented pattern, similar to the pattern observed in chemical-induced muscle cell death (26) (Supplementary Material, Fig. S6 ). At 3 d.p.f., GFP-positive muscle fibers that did not present any signs of degeneration, as indicated by tears or detachment from the myotendenous junction, already exhibited a fragmented mitochondrial network compared with tubular mitochondria observed in the control sibling embryos (Fig. 4) .
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Moreover, at later stages (4 and 6 d.p.f.), GFP-positive fibers analyzed in homozygous dmd pc2+/+ larvae, including those that were still attached to their corresponding myoseptum, exhibited a strongly fragmented mitochondrial pattern, whereas mitochondria of the control siblings were all tubular (Supplementary Material, Fig. S6 and S7) . Altogether, these Figure 3 . Effect of control, drp-1, cyc-2.1 and itr-1 RNAi on mitochondrial morphology of muscles in LS761 dys-1(cx18) ccIs4251; hlh-1(cc561) mutant nematodes. (A) Representative images of mitochondrial pattern observed in muscles of LS761 dys-1(cx18) ccIs4251; hlh-1(cc561) animals subjected to L4440 empty vector (control), drp-1, cyc-2.1 or itr-1 RNAi. (B) Distribution of muscle cells with fragmented, tubular, intermediate or absent mitochondrial network per animal. Animals were grown for 7 days at 158C and were fed with dsRNA-expressing bacteria (cyc-2.1 and itr-1 RNAi treatment were starting from day 4). Mean of 20 nematodes + standard error of the mean. Different from corresponding control L4440 at * P , 0.05, * * P , 0.02, * * * P , 0.01.
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Cytochrome c is involved in C. elegans dystrophic muscle cell death Inhibition of mitochondrial fission or cyclophilin D reduced muscle degeneration in dystrophic worms. We thus wondered whether interfering with pro-apoptotic factors released from mitochondria when mPT occurs would reproduce the effect of CsA treatment or of cyn-1 RNAi on muscle degeneration. We focused on cytochrome c, which is well known to participate in cell death in mammals after being released from mitochondria (15, 27) . Based on the C. elegans database (www.wormbase.com) and on the murine sequence of cytochrome c (CAA25899.1), three genes were selected for further analysis: cyc-1, cyc-2.1 and cyc-2.2 (Supplementary Material, Table S2 ) (28) . Only the knockdown of cyc-2.1 significantly reduced muscle degeneration in dys-1; hlh-1 double mutants (Fig. 5A) . Knockdown of cyc-1 led to lethality, whereas RNAi against cyc-2.2 did not induce any detectable phenotype. However, cyc-2.1 RNAi induced growth retardation when worms were treated starting from the first larval stage, thus hampering the readout of the time-dependent muscle degeneration phenotype ( Fig. 5A and E) . In order to ensure that the beneficial effect on muscle degeneration was not due to growth rate retardation, cyc-2.1 RNAi treatment was started at different time points of the development of the worms.
Muscle degeneration is usually scored in adult worms at day 8 of culture. Therefore, worms were cultured on bacteria unable to produce cyc-2.1 dsRNA and transferred on cyc-2.1 dsRNAproducing bacteria at different days of culture (days 2 to 7). When cyc-2.1 RNAi treatment was initiated at day 3, 4 or 5 of worm culture, no growth retardation was detected and muscle degeneration was still significantly reduced ( Fig. 5A and E) . This genetic treatment significantly reduced the paralysis observed in dys-1; hlh-1 double mutants, whereas it had no specific effect on locomotion behavior of dys-1 single mutants or wild-type worms (Fig. 5F ). cyc-2.1 RNAi treatment started at day 6 or 7 had no detectable effect on muscle degeneration (Fig. 5A) . The tissue expression of cyc-2.1 was then investigated through the expression of GFP driven by the putative promoter of cyc-2.1. At all larval stages as well as in adults, GFP expression was observed in the excretory cell, in the nervous system, in intestine cells, in the pharynx and in body-wall muscles (Fig. 6) . In a majority of transgenic worms, a predominant expression was observed in the intestine and in muscle cells compared with other tissues expressing GFP. The strong expression in bodywall muscles is consistent with the observed effect of cyc-2.1 RNAi-mediated knockdown on muscle degeneration.
Cytochrome c/IP3R interaction is implicated in muscle degeneration
Finding cytochrome c to be involved in dystrophin-dependent muscle degeneration tends to confirm that mitochondria play a significant role in DMD. However, the C. elegans ortholog of APAF-1 encoded by the ced-4 gene does not contain the WD40 repeat domain responsible for cytochrome c binding (29) . It has, therefore, been assumed that, in C. elegans, cytochrome c is not involved in cell death. Our results thus provide the first evidence that cytochrome c can contribute to cell death in C. elegans. We then aimed to establish how cytochrome c contributes to muscle degeneration in dystrophic worms. In rats, cytochrome c was shown to bind to the cytosolic C-terminal sequence of type 1 IP3R (30). We, therefore, analyzed whether CYC-2.1 is able to bind to the C. elegans IP3R ortholog, ITR-1, and whether this interaction is involved in the muscle degenerative process in dys-1; hlh-1 double mutants.
In mammals, the critical region responsible for the binding of cytochrome c has been attributed to the amino acids 2621-2636 of IP3R (31) . This sequence is well conserved from invertebrates to humans (Fig. 7A and B) . To ensure proper cloning of the putative cytochrome c-binding sequence-named in the following 'Sp-cyc', for cytochrome c sponge-a cDNA fragment carrying ITR-1 C-terminus encoding sequence starting from the end of the last transmembrane domain of ITR-1 and a second fragment encoding the same peptide fused to an HA-tag, Sp-cyc-HA, were generated (Fig. 7A) .
The Sp-cyc-and Sp-cyc-HA-encoding fragments as well as a cDNA encoding the full-length CYC-2.1 protein were cloned into yeast two-hybrid bait and prey plasmids. Yeast two-hybrid experiments confirmed the interaction of both peptides, Sp-cyc and Sp-cyc-HA, with the full-length CYC-2.1 protein (Fig. 7C) . In addition, Sp-cyc and Sp-cyc-HA peptides were able to interact with themselves, which is in accordance with a previous study that identified an oligomerization-binding site in the IP3R C-terminus (32). 
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Subsequently, the Sp-cyc-and Sp-cyc-HA-encoding DNA fragments were expressed in dys-1; hlh-1 double mutants under the control of the muscle promoter Pmyo-3. The HA-tagged peptides, Sp-cyc-HA, were detected in muscle cells by immunostaining, thus indicating that the constructs were correctly expressed (Fig. 7D) .
Two independent lines per construct (expressing the Sp-cyc or Sp-cyc-HA peptide) were generated. In all these lines, a significant reduction of muscle degeneration was observed in transgenic worms compared with non-transgenic siblings (Fig. 7E) . Moreover, owing to mosaic expression of transgenes in C. elegans, the peptides were expressed in only 50-70% of muscle cells, suggesting that their effects on muscle degeneration were under-evaluated in this study ( Fig. 7D and 8) .
Although the Sp-cyc and Sp-cyc-HA peptides are expressed during all developmental stages, no itr-1 knockdown-like phenotypes such as growth retardation, sterility and embryonic lethality were observed in the transgenic lines (data not shown) (33) . Moreover, the Pmyo-3 promoter induced expression of the SP-cyc and Sp-cyc-HA peptides in body-wall muscle cells as well as in somatic contractile sheath cells. A previous study showed that the alteration of ITR-1 function in these cells leads to an inhibition of sheath contractile activity (34) . In our experiments, sheath contraction cycles remained unchanged in the presence of the peptides, suggesting that the SP-cyc and Sp-cyc-HA peptides did not interfere with ITR-1 oligomerization and did not disturb endogenous ITR-1 function (data not shown).
These results suggest that, in C. elegans, cytochrome c can bind to ITR-1 and thereby contribute to muscle degeneration. Therefore, it is likely that the sponge peptides reduce muscle degeneration in the dystrophic worms by disturbing the interaction between cytochrome c and ITR-1.
ITR-1 is required for muscle degeneration
The results obtained with cytochrome c sponges suggest that the calcium channel ITR-1 plays a role in dystrophin-dependent muscle degeneration. We, thus, analyzed the effect of itr-1 Figure 5 . Effects of gene knockdowns and pharmacologic treatments on muscle degeneration, locomotion behavior and growth rate of nematodes. (A) Effects of RNAi-mediated knockdown of putative cytochrome c genes (cyc-1, cyc-2.1 and cyc-2.2) on muscle degeneration in dys-1(cx18); hlh-1(cc561) mutant nematodes. (B) Muscle degeneration in dys-1(cx18); hlh-1(cc561) mutant nematodes after knockdown of the C. elegans itr-1 gene, which encodes an ortholog of the mammalian IP3R family and of different genes (plc-1 to plc-4, pll-1 and egl-18) encoding putative orthologs of the main IP3R regulators, i.e. PLC. (C and D) Muscle degeneration in dys-1(cx18); hlh-1(cc561) animals after 2-APB or U-73122 exposure, respectively. (E) Effect of dsRNA exposure on growth rate of dys-1(cx18); hlh-1(cc561) double mutants, dys-1(cx18) single mutants, and wild-type (wt) worms. Growth rate corresponds to the time (in hours) from eggs to reproductive adult worms. (F) Effect of knockdown experiments on locomotion rate of dys-1(cx18); hlh-1(cc561), dys-1(cx18) and wild-type (wt) animals. Animals were grown for 8 days at 158C. DX/8 correspond to days when animals were transferred from control plates (bacteria carrying the empty vector L4440) to plates seeded with bacteria expressing dsRNA (RNAi-mediated knockdown). Mean of 20 nematodes + standard error of the mean. Different from control at * P , 0.05, * * P , 0.02, * * * P , 0.01. 1, growth retardation; 2, embryonic lethality; 3, sterility; 4, egg laying increased.
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knockdown on muscle degeneration in dys-1; hlh-1 double mutants. RNAi treatment against itr-1 significantly reduced the number of degenerating muscle cells (Fig. 5B) . According to previous studies, RNAi-mediated knockdown of itr-1 induced growth retardation as well as sterility and embryonic lethality in the progeny of worms treated during the entire culture period of 8 days ( Fig. 5B and E) (33) . Therefore, dystrophic worms were subjected to itr-1 RNAi at different time points of development. The aforementioned phenotypes were no longer detectable when worms were treated starting from day 3, whereas a significant beneficial effect on muscle degeneration was observed for all treatments starting from day 3, 4 or 5 of culture ( Fig. 5B and E) . In addition, this treatment did not affect locomotion or growth rate of dys-1 single mutants and wild-type worms ( Fig. 5E and F) . However, the impact of itr-1 knockdown on muscle degeneration was not accompanied by a significant gain of motility of dys-1; hlh-1 double mutants (Fig. 5F ). Finally, dys-1; hlh-1 double mutants treated with the IP3R inhibitor aminoethoxydiphenyl borate (2-APB) showed significantly less muscle degeneration compared with control worms (Fig. 5C ). These observations, thus, demonstrated a role for the ITR-1 calcium channel in muscle degeneration. Since IP3R activity is mostly regulated by inositol trisphosphate (IP3), which is generated by phospholipase C (PLC), we further analyzed whether knocking down C. elegans PLC orthologs would reproduce the effects of itr-1 RNAi. Six PLC orthologs encoding genes are known in C. elegans, named plc-1 to -4, pll-1 and egl-8 (35) (Supplementary Material, Table S2 ). RNAi knockdown experiments against these genes did not lead to a significant reduction of muscle degeneration of dys-1; hlh-1 double mutants (Fig. 5B) . Combinatory experiments were also conducted but did not lead to significant outcomes (data not shown). In addition, the PLC inhibitor U-73122 failed to significantly modify muscle degeneration in dys-1; hlh-1 double mutants (Fig. 5D ).
ITR-1 and cytochrome c play a role in both muscle degeneration and mitochondrial dynamics
Our results indicate that the interaction between ITR-1 and CYC-2.1 plays a role in muscle degeneration of dystrophic nematodes. We, thus, questioned whether these two proteins contribute to the fragmentation of the mitochondrial network observed in LS761 dys-1(cx18) ccIs4251; hlh-1(cc561) nematodes. LS761 animals subjected to cyc-2.1 or itr-1 RNAi-mediated knockdown starting from day 4 of culture presented not only significantly fewer degenerating muscle cells but also significantly less muscle cells with a fragmented mitochondrial pattern, compared with control worms ( Fig. 3;  Supplementary Material, Fig. S8 ). In addition, the expression of the sponge peptide Sp-cyc in the body-wall muscle cells of LS761 worms also led to a significant reduction of mitochondrial fragmentation in mCherry-positive muscle cells that inherited the construct compared with neighboring nontransgenic cells (Fig. 8) . 
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DISCUSSION
Here, we demonstrate that CsA is beneficial toward dystrophindependent muscle degeneration in the nematode C. elegans. Efficient doses of CsA upon muscle degeneration range from 1 nM to 1 mM in the culture medium, thus revealing a high efficiency and bioavailability of the drug into the nematode. Indeed, most of the drugs identified as being beneficial toward muscle degeneration in the nematode DMD model presented an optimal effect in a dose range from 100 mM to 2 mM in the medium [(8), L.S., unpublished results]. Similar results have been reported within the mdx mouse model. Administration of 10 mg/kg/day of CsA by feeding led to improvement of outcomes in mdx mice and suggested that this compound may be of interest for humans (19) . However, a recent clinical trial showed that this drug, when delivered at relative high dose (4 mg/kg/day), did not significantly improve muscle functions of DMD patients (36) . Our results show that, in the C. elegans DMD model, CsA treatment loses its beneficial effect against muscle degeneration when used at doses .10 mM in the medium. Accordingly, high-dose treatment of mdx mice (30 mg/kg/day intraperitoneally) did not lead to any benefit, and was rather deleterious for muscles in the dystrophic context (37) . Considering body surface area normalization method, administration to a child of 4 mg/kg/day of a drug corresponds to 33 mg/kg/day in adult mice (38) . This dose might thus be too high to induce any beneficial effect in humans. It is noteworthy that no deleterious effect of the drug was reported in the human trial. The deleterious effect in mice was attributed to an interference with muscle regeneration due to calcineurin inhibition. Besides lethal toxicity at the highest dose tested, no deleterious muscular effect was observed in C. elegans, which is potentially due to the lack of muscle regenerative processes in the nematode. It is also well established that mice possess a more effective regenerative capacity than humans, which may also explain that no deleterious effect on muscles was reported in the human trial. So far, results obtained with C. elegans and mice suggest that the optimal dose of CsA that could lead to potential beneficial effects may have been missed in humans.
CsA was initially suspected to be beneficial against the inflammatory processes that take place in the muscles of DMD patients and mdx mice (19, 36) . However, since C. elegans lacks an inflammatory system, at least in muscles, finding CsA to be beneficial toward dystrophin-dependent muscle degeneration supports the hypothesis that the effect of this compound on muscle degeneration involves mechanisms other than immunosuppression. Our study shows that, in the nematode, low doses of CsA act, at least in part, through cyclophilin D to reduce muscle degeneration. Interestingly, the CsA analog Debio025 was also found to improve the outcomes in mdx mice (39) . Since Debio025 lacks immunosuppressive activity, it has been suggested that this drug reduces muscle degeneration through the regulation of mPTP opening. This hypothesis was further supported by the observation that genetic inhibition of cyclophilin D improves mdx mouse phenotypes, reinforcing the relevance of this protein as a potential therapeutic target against DMD (40) . In addition, cyclophilin D was further linked to muscle cell death in collagen VI myopathic mice, thus suggesting that cyclophilin D inhibition may be relevant as a treatment for myopathies in general (41) .
The relevance of cyclophilin D as a therapeutic target is also confirmed by our observation of a key role for mitochondrial dynamics in the early process of muscle degeneration in C. elegans and most likely in zebrafish. Cyclophilin D directly regulates calcium-dependent mPT and cellular necrosis. Mice lacking cyclophilin D present protection against necrotic cell death after ischemic injury, and mitochondria isolated from these mice are resistant to calcium-induced swelling (16) . Cytosolic calcium overload has been observed in mdx mouse muscle fibers as well as in humans, and we previously showed that Ca 2+ transients play a critical role in the DMD nematode model (9) . This excess of calcium may be up-taken by mitochondria, and thus lead to mPT, increased mitochondrial fission, as well as cytochrome c release, and all these phenomena may promote muscle cell degeneration. This hypothesis is further supported by our observations showing that inhibiting mPTP opening with CsA treatment and/or cyn-1 knockdown, reducing mitochondrial fission with drp-1 knockdown as well as inhibiting cytochrome c via cyc-2.1 knockdown, all improve the dystrophic muscle phenotype in the C. elegans DMD model (Fig. 9) .
The beneficial effect of cytochrome c knockdown toward dystrophic muscle tends to confirm that mitochondria play a significant role in dystrophin-dependent muscle degeneration. However, cytochrome c may not promote directly apoptosome formation in the nematode, as the C. elegans APAF-1 heterologous CED-4 lacks the cytochrome c-binding domain (29) . Thus, in C. elegans, cytochrome c may promote muscle degeneration by contributing to the increase of Ca 2+ intake and accumulation in mitochondria through its interaction with the calcium channel IP3R, thereby amplifying subsequent events involved in cell death. Rizzuto et al. (42) demonstrated that IP3R is directly juxtaposed to mitochondria, and mediates Ca 2+ transient between these organelles. It has been further determined that cytochrome c interaction with the C-terminus of the IP3R is critical for Ca 2+ signaling in cell death, resulting in Ca 2+ poisoning of the mitochondria (31). The mitochondrial Ca 2+ overload induced by IP3R activity has been described to occur prior to apoptosome formation, and seems to be a crucial step for global caspases activation, which can in turn lead to IP3R cleavage and dysregulation (43) . Additionally, under high Ca 2+ concentration conditions, calpains are also involved in the N-terminal degradation of the IP3R, leading to constitutive activation and further Ca 2+ depletion of the ER (44) (Fig. 9) . The degradation of the IP3R N-terminal region (which carries the IP3-binding site) would explain why in our study the knockdown of PLC-encoding genes or the chemical inhibition of PLC did not lead to a significant beneficial effect upon muscle degeneration. Indeed, PLC is required to generate IP3. Thus, if, in dystrophic muscles, the Ca 2+ transient through IP3R were no longer regulated by IP3 release, PLC inactivation would have no effect. However, we cannot rule out the possibility that other PLC homologs, than the six described so far in C. elegans (35, 45) , exist and interact with ITR-1 in the muscle degenerative process. After all, it remains unclear whether cytochrome c plays a direct role in apoptosome formation in C. elegans.
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However, our data suggest that this protein may amplify mitochondrial Ca 2+ overload and subsequently contributes to cell death. More experiments need to be performed to fully understand its role in cell death pathways in C. elegans.
Mitochondrial disorders are associated with a large panel of pathologies including muscle diseases (46) . Defects in mitochondrial localization and mitochondrial functions were recently reported in the mdx mouse model for DMD (47) . However, it remains to be established whether and how these defects contribute to the muscle degenerative process and could be targeted in order to reduce the progression of muscle degeneration. Physiologic mitochondrial functions are maintained by the interplay of fusion and fission processes (11) . We show that in dystrophic C. elegans muscles, mitochondrial fission predominates and that the inactivation of the fission-promoting gene drp-1 is beneficial toward muscle degeneration. Moreover, increased mitochondrial fission upon muscle degeneration does not seem to be restricted to C. elegans since mitochondrial fragmentation is also an early hallmark of muscle degeneration in a zebrafish model for DMD. These observations suggest that mitochondrial morphology alterations could be a universal pattern of dystrophic muscles and an early process in the progression of dystrophindependent muscle degeneration. Thus, targeting mitochondrial dynamics could provide therapeutic strategies for muscle diseases.
CONCLUSION
Our results suggest that CsA treatment may be useful against DMD. Indeed, even if a recent clinical trial shows no direct evidence of its interest for patients, except for its anti-inflammatory effect in regard to gene and cell therapy, a beneficial effect on muscle degeneration at low dose has potentially been missed. It seems that its effect on mPT through cyclophilin D inhibition is key to the muscle protection observed in the C. elegans DMD model and requires the application of low doses of CsA. Our study also revealed that mitochondrial dynamics plays an early and crucial role in muscle degeneration. Targeting mitochondrial permeability and dynamics should be explored further in order to establish whether their modulation could delay the progression of the disease in humans. In this regard, the use of Debio025 or other specific mPTP inhibitor might be more relevant than CsA in new clinical trials.
Additionally, this study suggests for the first time, to our knowledge, that (i) mPT may exist in C. elegans, and (ii) cytochrome c can be implied in muscle cell death in the nematode, at least through its interaction with the calcium channel IP3R, and that their interplay seems to play a role in mitochondrial dynamics.
MATERIALS AND METHODS
Strains and culture conditions
C. elegans strains were cultured at 158C on 55 mm Petri dishes containing nematode growth medium (NGM) agar and a lawn of Escherichia coli OP50 unless stated otherwise. The following C. elegans strains were used: wild-type N2, LS292 dys-1(cx18) I, PD4613 hlh-1(cc561) II, LS587 dys-1(cx18) I;hlh-1(cc561) II, PD4251 ccIs4251 I;dpy-20(e1282) IV, LS541 dys-1(cx18) ccIs4251 I, LS762 ccIs4251 I;hlh-1(cc561) II and LS761 dys-1(cx18) ccIs4251 I;hlh-1(cc561) II;dpy-20(e1282) IV (Supplementary Material, Table S1 ). The ccIs4251 transgene contains Pmyo-3::Ngfp-lacZ (nuclear GFP localization) and Pmyo-3::Mtgfp (mitochondrial GFP localization). All strains were grown at 158C, which is the permissive temperature for the thermo-sensitive mutation hlh-1(cc561) (4). The N2, PD4613 and PD4251 strains were obtained from the Caenorhabditis Genetics Center.
Preparation of chemical compounds and drug-containing plates
All pharmacologic compounds were obtained from Sigma Chemical Co. (St Louis, MO, USA). Methazolamide (Meth) was used as a positive control to reduce muscle degeneration ( 8) . Concentrated solutions (10×) of each drug were prepared in DMSO. C. elegans tolerates DMSO up to a final concentration of 2% vol/vol. Compounds were added to liquid NGM agar that had been autoclaved and cooled to 558C, and the media was immediately mixed and dispensed into Petri dishes. Depending on the experiment, a drop of E. coli OP50 bacteria, empty plasmid L4440 containing HT115 bacteria or HT115 bacteria expressing dsRNA were added on top of the medium. C. elegans is permeable to aqueous and organic molecules, and it is admitted that drugs penetrate the worms both by diffusion through the cuticle and ingestion (8) . Drugs used in this study were CsA, Meth, 2-APB, U-73122 hydrate.
Preparation of RNAi plates and generation of dsRNA-expressing bacteria
RNAi experiments were performed on NGM plates supplemented with 100 mg/ml ampicillin, 12.5 mg/ml tetracycline and 2 mM IPTG (NGM-ATI). For each bacteria clone carrying an RNAi plasmid, one colony was cultured overnight at 378C in 2 ml of LB medium supplemented with 100 mg/ml ampicilin and 12.5 mg/ml tetracycline (LBAT). The day after, 0.01 volume of this preculture was added in 1 volume of LBAT and incubated at 378C. When the culture had reached 0.45 -0.5 DO, 2 mM IPTG was added. At 0.7 DO, 100 to 200 ml of the bacteria culture was seeded on NGM-ATI plates. Plates were allowed to dry at room temperature for at least 3 days before experiments. HT115 bacteria strains producing dsRNA for cyn-2, cyn-3, cyn-4, cyn-6, cyn-8, cyn-9, cyn-11, cyn-12, itr-1, plc-1, plc-2, plc-3, plc-4, pll-1, egl-8, cyc-1, cyc-2.1, cyc-2.2, drp-1, cah-4 and pos-1 were obtained from the C. elegans RNAi library (48) . Clones for cyn-1, cyn-5, cyn-7, cyn-10, cyn-13, cyn-14, cyn-15 and cyn-16 were constructed for the study. Constructs were obtained by amplification of 400-600 pb of genomic DNA of either gene and cloned into the RNAi feeding vector L4440 (for primers, see Supplementary Material, Fig. S9 ). Note that pos-1 knockdown is used as an RNAi efficiency control in every experiments, which resulted in nearly 100% embryonic lethality.
Drug and/or RNAi assays
Three gravid adults of the N2, PD4251, LS292, LS541 or LS762 strains and five gravid adults of the LS587 or LS761 strains were put on plates for one night and removed, so as progeny was exposed to drug and/or dsRNA from hatching to fixation. All worms were fixed and observed at day 8 of culture, unless stated otherwise. Before collecting each population, the plates were observed to ensure that the bacteria layer has not been depleted before the end of the assay. As RNAi efficiency control, pos-1 RNAi knockdown performed in parallel resulted in nearly 100% embryonic lethality. As RNAi-negative control, plates seeded with empty plasmid L4440 containing bacteria were used. All experiments were performed in duplicate and were repeated at least three times.
Scoring of muscle degeneration
The 95 body-wall muscles of C. elegans are organized into four quadrants (ventral right and left, dorsal right and left) each of which consists of 23 or 24 diamond-shaped muscle cells, arranged in two staggered rows (Supplementary Material,  Fig. S1 ). Unless stated otherwise, muscle observation was performed on worms after 8 days of culture at 158C. All worms were collected and fixed for 1 h in 1 ml of PBS supplemented with 30 ml of 37% formaldehyde. Each sample was stained by rhodamine-coupled phalloidin, a marker of filamentous actin. Staining was performed according to Waterston et al. (49) . Slides were observed on a Zeiss Axioplan microscope. A bodywall muscle cell is considered degenerating when its actin fibers are fragmented or destroyed (Supplementary Material, Fig. S1B ) (4) . Only the two most visible muscle quadrants of each animal were scored. A minimum of 20 worms per conditions were examined per experiments. Experiments were repeated three to five times. Numbers were compared by a Student's t-test.
Locomotion and growth rate
To estimate the locomotion rate of nematodes, worms cultured for 8 days at 158C were scored for the number of body bends generated during an interval of 1 min on NGM plates without bacteria. A body bend was defined as one complete sinusoidal movement from maximum to minimum amplitude and back again. The growth rate refers to the time from F0 eggs to the first F1 eggs (generation time). A minimum of 20 worms were examined. Numbers were compared by a Student's t-test.
cyc-2.1::GFP construct and localization
Approximately 1 kb upstream of the ATG start codon of cyc-2.1 was amplified by PCR (forward primer: AATTGTCGACC-CACTTCGCCTAAGTTGCGG; reverse primer: AAT-TACCGGTGTTGAACCCTTAAAATACAG). This fragment containing the putative endogenous promoter of the cyc-2.1 gene was cloned upstream of the GFP-encoding sequence in pPD95.75 (kindly provided by A. Fire, Stanford University School of Medicine), resulting in plasmid pJG03. Wild-type N2 hermaphrodite young adults were injected with 25 ng/ml pCFJ68 (Punc-122::GFP) as selection marker (Addgene), and 10 ng/ml Pcyc-2.1::GFP containing plasmid. Plasmid microinjection was performed as described (50) . Individual F1 worms expressing GFP in coelomocytes (due to the expression of the Punc-122::GFP transgene) were isolated. Four independent stable transgenic lines were isolated, as defined by F1 giving transgenic progeny. Transgenic worms (50, all stages) were observed using a fluorescence microscopy on a Zeiss LSM 510 Meta fluorescence confocal microscope so as to detect the expression pattern of the Pcyc-2.1::GFP transgene.
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Confocal imaging and image treatment
All C. elegans images presented in this manuscript were recorded using a Zeiss LSM 510 Meta fluorescence confocal microscope at room temperature, and the files were processed and converted under ImageJ environment.
Mitochondrial morphology analysis
For mitochondrial analysis, C. elegans strains were grown at 158C for 6, 7, 8 and 9 days in the presence or absence of drugs and/or specific dsRNA-expressing bacteria. To amplify the cytochrome c binding sequence encoded by the itr-1 gene, a PCR fragment encompassing the full itr-1 C-terminal sequence (starting from the end of the last transmembrane domain) was amplified using C. elegans cDNA material (primers available in Supplementary Material, Fig. S9 ) (this fragment encodes ITR-1 amino acids sequence 2703-2846 and is named Sp-cyc). An HA-tag sequence was introduced in the 3 ′ primer for the construct Sp-cyc-HA to allow in situ validation of the peptide expression in the nematode. In addition, forward and reverse primers contained an XbaI and NcoI site, respectively. PCR products were introduced in the XbaI/NcoI sites of the pKG123 plasmid, downstream of a muscle-specific promoter (Pmyo-3) and upstream of the unc-54 3 ′ UTR. Resulting plasmids were named pKG160 and pKG159, respectively. Young adult hermaphrodites of the N2 strain were injected with 25 ng/ml pKG160 (Pmyo-3::Sp-cyc::HA-tag::unc-54 3 ′ UTR) or pKG159 (Pmyo-3::Sp-cyc::unc-54 3 ′ UTR) and with (i) 2.5 ng/ml pCFJ90 (Pmyo-2::mCherry) as selection marker (Addgene) for the construct with HA tag, or (ii) with 2.5 ng/ml pCFJ90 (Pmyo-2::mCherry) and 5 ng/ml pCFJ104 (Pmyo-3::mCherry) (Addgene) as selection markers for the construct without an HA tag. Plasmid microinjection was performed as described (50) . Individual wild-type F1 expressing mCherry in pharyngeal muscles were isolated and two different lines retained for each construct that were positive for the injection marker in the F2 generation. Transgenics lines were then crossed with the LS761 line to test the effect of tagged or not tagged sponges against muscle degeneration. Expression of the Sp-cyc-HA construct was assessed in N2, checking the presence of a mosaic HA signal in the muscle tissue. Worms were analyzed by immuno-chemistry on whole-mount preparations as described by Benian et al. (51) . Secondary Alexa 555 goat antimouse antibody (Invitrogen) was used to reveal the primary mouse anti-HA antibody (Santa Cruz). Imaging was carried out as stated above.
Yeast two-hybrid experiments
To carry out this yeast two-hybrid assays, bait and prey vectors from Clontech (Palo Alto, CA, USA) were used. The pAS2-1 bait plasmid contains the Gal4 DNA binding domain (Gal4-BD) upstream of a polylinker. The pACT-2 prey plasmid contains the Gal4 activation domain (Gal4-AD) upstream of a polylinker.
The coding sequences of CYC-2.1 (amino acids 1 -111) and ITR-1 C-ter (amino acids 2703-2846, named Sp-cyc) were amplified by PCR using C. elegans cDNA with the use of appropriate primers integrating NcoI and XmaI restriction sites, respectively, at 5 ′ and 3 ′ ends of each PCR product (Supplementary Material, Fig. S9 ). For the Sp-cyc-HA construct, the same ITR-1 C-ter (amino acids 2703 -2846) coding sequence as for SP-cyc was amplified by PCR; the HA coding sequence was integrated to the PCR product through the 3 ′ primer (Supplementary Material, Fig. S9 ). All PCR products were digested by NcoI/XmaI and cloned into the NcoI/XmaI sites of the pACT2 as well as the pAS2-1 plasmids. The resulting bait plasmids were named pKG162 (Sp-cyc sequence in pAS2-1), pKG164 (Sp-cyc-HA in pAS2-1), pKG166 (cyc-2.1 in pAS2-1); the resulting prey plasmids were named pKG161 (Sp-cyc sequence in pACT2), pKG163 (Sp-cyc-HA in pACT2), pKG165 (cyc-2.1 in pACT2). Bait plasmids were transformed into the yeast strain CG1945 and prey plasmids into the yeast strain Y187 using the LiAc transformation procedure (Clontech, Yeast protocols Handbook, PT 3024-1). Interactions 
Zebrafish strains, injection, sorting and imaging
The dmd pc2+/2 zebrafish line was described in Berger et al. (25) . Zebrafish were bred and maintained by standard protocols approved by MAS/2009/05. All experiments were approved also by the University of Sydney Animal Ethics Committee. In aiming to express GFP in zebrafish muscle mitochondria, pSCAC-69 plasmid (courtesy of Dr Seok-Yong Choi), which carries GFP sequence with a mitochondrial targeting signal, was digested by XhoI/HindIII to remove the pEF1A promoter. Polymerase I large Klenow fragment was then used to generate blunt end. Muscle-specific alpha-actin promoter was cut from P5EA-acta1 plasmid (courtesy of Thomas Hall) using AvaI/ EcoRI, made blunt and cloned upstream of the GFP sequence, final plasmid was named JG013. Thirty picograms of JG013 plasmid were injected into one-cell-stage embryos obtained by incrossing PC2
+/2 animals. GFP-positive embryos were sorted using a fluorescent stereo-microscope at 1 d.p.f. Homozygous DMD dmd pc2+/+ larvae start to die from 9 d.p.f. and can usually not survive more than 30 d.p.f. Homozygous dmd pc2+/+ embryos and larvae can, therefore, only be obtained by crossing heterozygous dmd pc2+/2 adults. Homozygous dmd pc2+/+ embryos were detected, at 3 d.p.f., by birefringence using polarized light and two circular polarized filters. dmd pc22/2 and dmd pc2+/2 control siblings and dmd pc2+/+ embryos and larvae were mounted in 1% low-melting agarose supplemented with 0.02% tricaine and scanned using an LSM710 confocal microscope.
